Name: Growth Signal
Brand: Nuragen
SKU: NRG-GROWTHSI

Growth Signal pairs two research peptides, CJC-1295 and Ipamorelin. Together they are studied for how they interact with the body's own growth hormone signalling, and are supplied strictly for laboratory research use.

How it is studied

In the research literature, CJC-1295 and Ipamorelin are examined as a complementary pair rather than in isolation. Studies look at how each compound engages a different point in the growth hormone signalling cascade, and how the two are thought to act together on the somatotroph cells of the pituitary. Investigations focus on mechanism and pathway behaviour, describing what the compounds signal rather than any outcome in a living subject.

The components and the pathway

CJC-1295 is a growth-hormone-releasing hormone (GHRH) analogue, studied for how it prolongs the signal that prompts the pituitary to release its own growth hormone. Ipamorelin is a selective growth hormone secretagogue that acts on the ghrelin receptor as a separate trigger for that same release. Positioned within the recovery pathway, the pair is researched for how these two distinct mechanisms converge on the body's endogenous GH axis.

How it sits in a responsible research programme

Growth Signal is intended as a defined reference material for controlled laboratory work, handled by qualified researchers under appropriate protocols. It is characterised by its molecular identity and its documented role in the research literature, not by any claim about what it may do for a person. Used this way, it supports method development, comparative study and mechanistic investigation within a research-use-only framework.

Composition

Component	CAS	Purity
CJC-1295	863288-34-0	Pending
Ipamorelin	170851-70-4	Pending

Type	Lyophilised powder
Presentation	Lyophilised powder
Appearance	White lyophilised powder
Storage	Store at 2-8°C, protected from light.
Dispatch	Delivered within 72 hours across the UK.

Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.

What is Growth Signal and what is its intended use?

Growth Signal is a research pairing of two peptides, CJC-1295 (a GHRH analogue) and Ipamorelin (a growth hormone secretagogue). It is supplied strictly for research-use-only laboratory work. It is not a medicine, supplement or treatment, and it is not intended for human or animal use.

How should it be handled and stored?

As with many research peptides, it is generally handled by trained personnel and stored refrigerated at 2-8C, protected from light, following the storage guidance supplied with the material and your own laboratory protocols. Careful handling supports the integrity of the reference material during study.

Do you provide dosing or usage guidance?

No. We provide information on what the compounds are and the pathway they are studied to act on. We do not provide dosing, administration instructions, protocols or medical advice, and nothing here should be read as guidance for use in people or animals.

Why are CJC-1295 and Ipamorelin studied together?

They are researched as a pair because each engages a different point in growth hormone signalling: CJC-1295 as a GHRH analogue that prolongs the releasing signal, and Ipamorelin as a secretagogue acting on the ghrelin receptor. Studying them together lets researchers examine how two distinct mechanisms converge on the same endogenous GH pathway.